Medicare Enrolled

Dr. Norbert Brehm, MD

Urology Physician · Corpus Christi, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
601 TEXAN TRL, Corpus Christi, TX 78411
3618846381
In practice since 2005 (20 years)
NPI: 1699761213 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brehm from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brehm? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brehm

Dr. Norbert Brehm is an urology physician in Corpus Christi, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brehm performed 7,423 Medicare services across 4,678 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brehm received a total of $2,634 from 24 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brehm is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in TX $2,634 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,423
Medicare services
Top 14% in TX for urology physician
4,678
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~371 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Manual urinalysis test with examination using microscope, non-automated 1,926 $4 $25
Office visit, established patient (30-39 min) 1,221 $92 $371
Bladder ultrasound after voiding 1,162 $8 $31
Blood draw (venipuncture) 480 $8 $15
Office visit, established patient (20-29 min) 461 $61 $257
PSA test (prostate cancer screening) 455 $18 $105
Leuprolide acetate (for depot suspension), 7.5 mg 246 $135 $750
Ceftriaxone antibiotic injection 186 $0 $30
Diagnostic exam of bladder and urethra using an endoscope 159 $179 $683
New patient office visit (45-59 min) 157 $122 $482
Office visit, established patient (10-19 min) 115 $36 $162
Insertion of temporary bladder tube 94 $32 $129
Hospital follow-up visit, moderate complexity 72 $62 $230
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 63 $25 $97
Imaging of urinary tract following injection of a contrast agent 61 $19 $104
Initial hospital admission, moderate complexity 61 $100 $377
Simple insertion of temporary bladder tube 56 $44 $178
Dilation of urethra using an endoscope 50 $232 $930
Drug injection, under skin or into muscle 50 $10 $41
Simple change of bladder tube 37 $67 $280
Electronic assessment of bladder emptying 36 $3 $22
Insertion of device into abdomen with pressure and urine flow rate study 35 $84 $310
Complex measurement of pressure of urine flow in bladder with voiding pressure studies 34 $151 $593
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings 33 $14 $102
Insertion of stent in ureter using an endoscope 33 $108 $543
Simple measurement of pressure of urine flow in bladder 29 $171 $650
New patient office visit (30-44 min) 21 $85 $324
Prostate cancer screening; prostate specific antigen test (psa) 18 $19 $105
Exam with injections of chemical for destruction of bladder using an endoscope 17 $123 $743
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope 17 $226 $952
Insertion of tube into ureter using an endoscope through bladder area 14 $41 $553
Biopsy of prostate gland 12 $166 $699
Ultrasound scan of pelvic region through rectum 12 $107 $582
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
21.1% medium
78.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,634
Total received (2018-2024)
Avg $376/year across 7 years
Bottom 45% in TX for urology physician
24
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,469 (93.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$444
2023
$360
2022
$376
2021
$830
2020
$126
2019
$150
2018
$348

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$838
Teleflex LLC
$400
ABBVIE INC.
$198
Janssen Biotech, Inc.
$182
Allergan Inc.
$153
Janssen Scientific Affairs, LLC
$117
UROVANT SCIENCES INC
$113
Myovant Sciences Inc.
$86
Endo Pharmaceuticals Inc.
$74
AbbVie Inc.
$65
Sumitomo Pharma America, Inc.
$49
Merck Sharp & Dohme LLC
$44
Boston Scientific Corporation
$44
Antares Pharma, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$37
Medtronic, Inc.
$33
UroGen Pharma, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$25
Dendreon Pharmaceuticals LLC
$24
UROGEN PHARMA, INC.
$20
TOLMAR Pharmaceuticals, Inc.
$18
PROCEPT BioRobotics Corporation
$16
BOSTON SCIENTIFIC CORPORATION
$15
HealthTronics Stone Solutions, LLC
$11
Top 3 companies account for 54.5% of total payments
Associated products mentioned in payments ›
AMS 700 CXR RTE Kit · AquaBeam Robotic System · BOTOX · BOTOX THERAPEUTIC · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - ERECTILE DYSFUNCTION · INTERSTIM · JELMYTO · KEYTRUDA · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · OPDIVO · ORGOVYX · PROVENGE · UroLift System · VESICARE · XIAFLEX · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $35 per 100 Medicare services performed
Looking for an urology physician in Corpus Christi?
Compare urology physicians in the Corpus Christi area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
11
Per 100K population
3.1
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Brehm is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Brehm experienced with manual urinalysis test with examination using microscope, non-automated?
Based on Medicare claims data, Dr. Brehm performed 1,926 manual urinalysis test with examination using microscope, non-automated services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brehm receive payments from pharmaceutical companies?
Yes. Dr. Brehm received a total of $2,634 from 24 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brehm's costs compare to other urology physicians in Corpus Christi?
Dr. Brehm's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brehm) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →